Elon Musk becomes the first person to reach a net worth of $400 billion Ivar AI

Ambcrypto.com

Crypto market cap surpasses France, UK GDPs – India, Japan next

Gizmodo.com

Un hallazgo en la Antártida podría cambiar el mercado energético

Forbes

The Push And Pull Of Sino-American Chip Politics

International Business Times

Taiwan Says China Carrying Out Huge Maritime Drills

newsBTC

Dogecoin About To Enter Phase Of Explosive Growth – Charts Reveal Massive Breakout

Biztoc.com

MicroStrategy Acquires $2.1B Worth of Bitcoin, Total Holdings Now Exceed 423,000 BTC

Biztoc.com

US Strategic Bitcoin Reserve Would Cause Tectonic Shifts In Personal Finance, Researcher Predicts

The Times of India

Adani Group vows ₹7.5 lakh crore investment across sectors

The Times of India

SoundHound: This AI stock rose 578% in 2024, how will it perform in 2025; why investors are gung-ho about this company? Here are its unique selling points

Meneame.net

EE.UU. anuncia nuevas restricciones tecnológicas a China para frenar su avance en microchips avanzados

Biztoc.com

Alphabet stock adds $136 billion in market value after it unveils quantum computing breakthrough

Xataka.com

Uruguay ha conseguido que las guerras y la crisis del petróleo no les afecte. La transición a las renovables ha sido su escudo

GlobeNewswire

Cell and Gene Therapy Market is expected to reach a revenue of USD 111.4 Bn by 2033, at 19.3% CAGR: Dimension Market Research

Eleconomista.es

Una nueva bajada de tipos por parte del BCE, la cuarta en el año, sobrevuela los mercados

Biztoc.com

Israel captures Syrian territory after Assad regime collapse

ABC News

Five years since its inception, a US development agency competes with China on global projects

The Atlantic

Khamenei Loses Everything

Eldiario.es

Los vecinos de Siria toman posiciones tras la caída de Al Asad mientras los insurgentes empiezan a gobernar

Biztoc.com

Bill Gates: How Entrepreneurs Can Benefit From Climate Change

$Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients$

GlobeNewswire

Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients